Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 16 February 2026, 17.45 hrs CET Melexis reports the purchase of 22,000 Melexis shares on Euronext Brussels in the period from 9 February 2026 to 13 February 2026, related to the share buy-back program announced on 10 December 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)9/2/20264,00055.3053.5055.90221,21510/2/20264,50056.9355.3557.50256,16711/2/20264,50056.3755.6556.85253,64712/2/20264,50056.1655.6557.35252,72713/2/20264,50055.9855.50...
Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 16 februari 2026, 17.45 uur CET Melexis meldt de aankoop van 22.000 Melexis-aandelen op Euronext Brussel in de periode van 9 februari 2026 tot 13 februari 2026, in het kader van het inkoopprogramma aangekondigd op 10 december 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)9/2/20264.00055,3053,5055,90221.21510/2/20264.50056,9355,3557,50256.16711/2/20264.50056,3755,6556,85253.64712/2/20264.50056,1655,6557,35252.72713/...
SYNERGIE : AMF - Déclaration mensuelle des droits de vote au 31 janvier 2026 Information Réglementée Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l’AMF) 31 janvier 2026Nombre total d’actions composant le capital24 362 000Nombre total de droits de vote exerçables39 503 117Nombre total de droits de vote, calculé sur la base de l’ensemble des actions composant le capital, y compris les actions privées de droits de vote*41 127 625 *Actions a...
Alfen reported broadly in line 4Q25 results but lowered its FY26 outlook. There is no tangible evidence of a pending volume-driven recovery in the 4Q25 performance of the Smart Grid and the EV Charging division. We increase our FY26 revenue estimate by 0.5% to the mid-point of Alfen's new revenue guidance and cut our FY26F adjusted EBITDA estimate by 6% to €26.1m. This reflects an adjusted EBITDA margin of 5.7%, slightly ahead of the company's mid-point guidance aiming for 5.5%. Management execu...
Two Directors at Sligro Food Group Nv bought 4,255 shares at 12.920EUR. The significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
The figures for 2025 showed pro forma revenue growth of 5%. TMV is planning for revenue growth of 0% to 3% in 2026. It emphasises that Q1 and Q2 are likely to be weak (the same quarters last year benefited from price increases in the SMB segment). Based on 2025 EPS (€0.75), TMV is currently trading at an unusually low P/E ratio of around 7 for the current year. The reasons for this are lost confidence, the underperformance of the acquired 1E to date and the structurally weak remote SMB business,...
Die vorläufigen 2025er-Zahlen brachten auf Pro-forma-Basis noch ein Umsatzwachstum von 5%. Für 2026 plant TMV mit 0% bis 3%igem Umsatzwachstum. Dabei wird betont, dass Q1 und Q2 schwach werden dürften (die Vorjahresquartale hatten von Preisanhebungen im SMB-Bereich profitiert). Auf Basis des 2025er EPS (€ 0,75) handelt TMV derzeit mit einem ungewöhnlich niedrigen KGV um 7 für das laufende Jahr. Gründe hierfür liegen in verlorenem Vertrauen, der bisherigen Unterperformance der zugekauften 1E und ...
ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...
Melexis: update on the share buy-back program Press release - Regulated Information Ieper, Belgium – 9 February 2026, 17.45 hrs CET Melexis reports the purchase of 10,000 Melexis shares on Euronext Brussels in the period from 2 February 2026 to 6 February 2026, related to the share buy-back program announced on 10 December 2025. Trade dateTotal shares purchasedAverage price (€)Min price (€)Max price (€)Buyback amount (€)2/2/2026-----2/2/2026-----2/2/2026-----2/2/20265,00053.8052.2056.55268,9952/2/20265,00053.1352.5053.45265,662TOTAL10,00053.4752.2056.55534,657 Under the current share bu...
Melexis: update over het aandeleninkoopprogramma Persbericht - Gereglementeerde informatie Ieper, België – 9 februari 2026, 17.45 uur CET Melexis meldt de aankoop van 10.000 Melexis-aandelen op Euronext Brussel in de periode van 2 februari 2026 tot 6 februari 2026, in het kader van het inkoopprogramma aangekondigd op 10 december 2025. InkoopdatumAantal verworven aandelenGemiddelde prijs (€)Laagste prijs (€)Hoogste prijs (€)Aankoop bedrag (€)2/2/2026-----2/2/2026-----2/2/2026-----2/2/20265.00053,8052,2056,55268.9952/2/20265.00053,1352,5053,45265.662TOTAAL10.00053,4752,2056,55534.657 Onde...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.